The development of DNA-biochips for rational prescribing of psychologists (Q11681): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Changed an Item) |
||
| Property / fund | |||
| Property / fund: European Regional Development Fund / rank | |||
Normal rank | |||
Revision as of 20:26, 6 June 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The development of DNA-biochips for rational prescribing of psychologists |
Project in Czech Republic financed by DG Regio |
Statements
11,073,961.0 Czech koruna
0 references
69.9 percent
0 references
31 October 2020
0 references
ESSENCE LINE, s.r.o.
0 references
50°4'11.50"N, 14°22'51.56"E
0 references
50°4'6.46"N, 14°23'8.41"E
0 references
15000
0 references
15000
0 references
Cílem projektu je vyvinout nový DNA-biochip pro racionalizovanou preskripci psychofarmak pro pacienty s psychiatrickým onemocněním a tím přinést prospěch nejen pacientovi, ale snížit náklady zdravotních pojišťoven. Přínosem projektu bude bezpečnější a efektivnější preskripce psychofarmak, což povede k úspěšnější farmakoterapii, zvýší komfort pacienta v podobě pozitivní terapie a sníží náklady na neefektivně aplikovaná psychofarmaka a negativní dopady na pacienta. a. (Czech)
0 references
The aim of the project is to develop a new DNA-biochip for a streamlined psychologist for patients with psychiatric illness, thereby bringing benefits not only to the patient but to reducing the costs of health insurance companies. The project will benefit from a safer and more effective psychopharmacy, leading to more successful pharmacotherapy, increasing the comfort of the patient in the form of positive therapy, and reducing the costs of the inefficiently applied psychopharmacy and the negative impacts on the pacemaker. (English)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/17_107/0012433
0 references